Undiagnosed disease in decedents with and without schizophrenia: an autopsy-based case-control study

References

• Wahlbeck K, Hällgren J, Westman J, et al. Excess mortality, causes of death and life expectancy in 270,770 patients with recent onset of mental disorders in Denmark, Finland and Sweden. PLoS One. 2013;8(1):e55176.
   PubMed Web of Science ®Google Scholar
• Kugathasan P, Stubbs B, Aagaard J, et al. Increased mortality from somatic multimorbidity in patients with schizophrenia: a Danish nationwide cohort study. Acta Psychiatr Scand. 2019;140(4):340–348.
   PubMed Web of Science ®Google Scholar
• Laursen TM, Munk-Olsen T, Gasse C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS One. 2011;6(9):e24597.
   PubMed Web of Science ®Google Scholar
• Plana-Ripoll O, Pedersen CB, Agerbo E, et al. A comprehensive analysis of mortality-related health metrics associated with mental disorders: a nationwide, register-based cohort study. The Lancet. 2019;394(10211):1827–1835.
   PubMed Web of Science ®Google Scholar
• Bitter I, Czobor P, Borsi A, et al. Mortality and the relationship of somatic comorbidities to mortality in schizophrenia. A nationwide matched-cohort study. Eur Psychiatr. 2017;45:97–103.
   PubMed Web of Science ®Google Scholar
• Nielsen RE, Uggerby AS, Jensen SOW, et al. Increasing mortality gap for patients diagnosed with schizophrenia over the last three decades – a Danish nationwide study from 1980 to 2010. Schizophr Res. 2013;146(1–3):22–27.
   PubMed Web of Science ®Google Scholar
• Lomholt LH, Andersen DV, Sejrsgaard-Jacobsen C, et al. Mortality rate trends in patients diagnosed with schizophrenia or bipolar disorder: a nationwide study with 20 years of follow-up. Int J Bipolar Disord. 2019;7(1):6.
   PubMedGoogle Scholar
• Crump C, Winkleby MA, Sundquist K, et al. Comorbidities and mortality in persons with schizophrenia: a Swedish national cohort study. Am J Psychiatry. 2013;170(3):324–333.
   PubMed Web of Science ®Google Scholar
• Friis K, Pedersen MH, Aaby A, et al. Impact of low health literacy on healthcare utilization in individuals with cardiovascular disease, chronic obstructive pulmonary disease, diabetes and mental disorders. A Danish population-based 4-year follow-up study. Eur J Public Health. 2020;30(5):866–872.
   PubMed Web of Science ®Google Scholar
• Friis K, Lasgaard M, Osborne RH, et al. Gaps in understanding health and engagement with healthcare providers across common long-term conditions: a population survey of health literacy in 29,473 Danish citizens. BMJ Open. 2016;6(1):e009627.
   PubMed Web of Science ®Google Scholar
• Buhagiar K, Parsonage L, Osborn DP. Physical health behaviours and health locus of control in people with schizophrenia-spectrum disorder and bipolar disorder: a cross-sectional comparative study with people with non-psychotic mental illness. BMC Psychiatry. 2011;11(1):104.
   PubMedGoogle Scholar
• Harangozo J, Reneses B, Brohan E, et al. Stigma and discrimination against people with schizophrenia related to medical services. Int J Soc Psychiatry. 2014;60(4):359–366.
   PubMed Web of Science ®Google Scholar
• Jørgensen M, Mainz J, Lange P, et al. Quality of care and clinical outcomes of chronic obstructive pulmonary disease in patients with schizophrenia. A Danish nationwide study. Int J Qual Health Care. 2018;30(5):351–357.
   PubMed Web of Science ®Google Scholar
• Oud MJ, Meyboom-de Jong B. Somatic diseases in patients with schizophrenia in general practice: their prevalence and health care. BMC Fam Pract. 2009;10(1):32.
   PubMedGoogle Scholar
• De Hert M, Correll CU, Bobes J, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011;10(1):52–77.
   PubMed Web of Science ®Google Scholar
• Smith DJ, Langan J, McLean G, et al. Schizophrenia is associated with excess multiple physical-health comorbidities but low levels of recorded cardiovascular disease in primary care: cross-sectional study. BMJ Open. 2013;3(4):e002808.
   PubMed Web of Science ®Google Scholar
• Gur S, Weizman S, Stubbs B, et al. Mortality, morbidity and medical resources utilization of patients with schizophrenia: a case-control community-based study. Psychiatry Res. 2018;260:177–181.
   PubMed Web of Science ®Google Scholar
• Heiberg IH, Jacobsen BK, Balteskard L, et al. Undiagnosed cardiovascular disease prior to cardiovascular death in individuals with severe mental illness. Acta Psychiatr Scand. 2019;139(6):558–571.
   PubMed Web of Science ®Google Scholar
• Nørgaard HCB, Schou Pedersen H, Fenger-Grøn M, et al. Schizophrenia and attendance in primary healthcare: a population-based matched cohort study. Scand J Prim Health Care. 2019;37(3):358–365.
   PubMed Web of Science ®Google Scholar
• Fagiolini A, Goracci A. The effects of undertreated chronic medical illnesses in patients with severe mental disorders. J Clin Psychiatry. 2009;70(3):22–29.
   PubMedGoogle Scholar
• van Hasselt FM, Schorr SG, Mookhoek EJ, et al. Gaps in health care for the somatic health of outpatients with severe mental illness. Int J Ment Health Nurs. 2013;22(3):249–255.
   PubMed Web of Science ®Google Scholar
• Lawrence D, Kisely S. Review: inequalities in healthcare provision for people with severe mental illness. J Psychopharmacol. 2010;24(4):61–68.
   PubMedGoogle Scholar
• Reilly S, Olier I, Planner C, et al. Inequalities in physical comorbidity: a longitudinal comparative cohort study of people with severe mental illness in the UK. BMJ Open. 2015;5(12):e009010.
   PubMed Web of Science ®Google Scholar
• Dornquast C, Tomzik J, Reinhold T, et al. To what extent are psychiatrists aware of the comorbid somatic illnesses of their patients with serious mental illnesses?—a cross-sectional secondary data analysis. BMC Health Serv Res. 2017;17(1):162.
   PubMedGoogle Scholar
• Bislev LS, Mortensen J, Gustafsson LN, et al. Poor quality of referral from mental to somatic hospitals. Dan Med J. 2015;62(6):A5085.
   PubMed Web of Science ®Google Scholar
• Brink M, Green A, Bojesen AB, Lamberti JS, et al. Excess medical comorbidity and mortality across the lifespan in schizophrenia.: a nationwide Danish register study. Schizophr Res. 2019;206:347–354.
   PubMed Web of Science ®Google Scholar
• Valderas JM, Starfield B, Sibbald B, et al. Defining comorbidity: implications for understanding health and health services. Ann Fam Med. 2009;7(4):357–363.
   PubMed Web of Science ®Google Scholar
• Charlson ME, Pompei P, Ales KL, et al. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–383.
   PubMedGoogle Scholar
• Perkins GD, McAuley DF, Davies S, et al. Discrepancies between clinical and postmortem diagnoses in critically ill patients: an observational study. Crit Care. 2003;7(6):R129–R132.
   PubMed Web of Science ®Google Scholar
• Shojania KG, Burton EC, McDonald KM, et al. Changes in rates of autopsy-detected diagnostic errors over time: a systematic review. JAMA. 2003;289(21):2849–2856.
   PubMed Web of Science ®Google Scholar
• Costache M, Lazaroiu AM, Contolenco A, et al. Clinical or postmortem? The importance of the autopsy; a retrospective study. 2014;9(3):261–265.
   Google Scholar
• Roulson J, Benbow EW, Hasleton PS. Discrepancies between clinical and autopsy diagnosis and the value of post mortem histology; a meta-analysis and review: discrepancies between clinical and autopsy diagnosis. Histopathology. 2005;47(6):551–559.
   PubMed Web of Science ®Google Scholar
• Buja LM, Barth RF, Krueger GR, et al. The importance of the autopsy in medicine: perspectives of pathology colleagues. Acad Pathol. 2019;6:237428951983404.
   Web of Science ®Google Scholar
• Banner J, Høyer CB, Christensen MR, et al. SURVIVE: let the dead help the living—an autopsy-based cohort study for mapping risk markers of death among those with severe mental illnesses. Scand J Forensic Sci. 2018;24(1):7–17.
   Web of Science ®Google Scholar
• Lynge E, Sandegaard JL, Rebolj M. The Danish National Patient Register. Scand J Public Health. 2011;39(7):30–33.
   PubMed Web of Science ®Google Scholar
• Mors O, Perto GP, Mortensen PB. The Danish Psychiatric Central Research Register. Scand J Public Health. 2011;39(7):54–57.
   PubMedGoogle Scholar
• Schmidt M, Schmidt SAJ, Sandegaard JL, et al. The Danish National Patient Registry: a review of content, data quality, and research potential. Clin Epidemiol. 2015;2015(7):449.
   Google Scholar
• Quan H, Sundararajan V, Halfon P, et al. Coding algorithms for defining comorbidities in ICD-9-CM and ICD-10 administrative data. Med Care. 2005;43(11):1130–1139.
   PubMed Web of Science ®Google Scholar
• Quan H, Li B, Couris CM, et al. Updating and validating the Charlson Comorbidity Index and Score for Risk Adjustment in hospital discharge abstracts using data from 6 countries. Am J Epidemiol. 2011;173(6):676–682.
   PubMed Web of Science ®Google Scholar
• Šprah L, Dernovšek MZ, Wahlbeck K, et al. Psychiatric readmissions and their association with physical comorbidity: a systematic literature review. BMC Psychiatry. 2017;17(1):2.
   PubMedGoogle Scholar
• Toftdahl NG, Nordentoft M, Hjorthøj C. Prevalence of substance use disorders in psychiatric patients: a nationwide Danish population-based study. Soc Psychiatry Psychiatr Epidemiol. 2016;51(1):129–140.
   PubMed Web of Science ®Google Scholar
• Sørensen T, Jespersen HSR, Vinberg M, et al. Substance use among Danish psychiatric patients: a cross-sectional study. Nord J Psychiatry. 2018;72(2):130–136.
   PubMed Web of Science ®Google Scholar
• Piano MR. Alcohol’s effects on the cardiovascular system. Alcohol Res. 2017;38(2):219–241.
   PubMed Web of Science ®Google Scholar
• Vancampfort D, Correll CU, Galling B, et al. Diabetes mellitus in people with schizophrenia, bipolar disorder and major depressive disorder: a systematic review and large scale meta-analysis. World Psychiatry. 2016;15(2):166–174.
   PubMed Web of Science ®Google Scholar
• Toalson P, Ahmed S, Hardy T, et al. The metabolic syndrome in patients with severe mental illnesses. Prim Care Companion J Clin Psychiatry. 2004;6(4):152–158.
   PubMedGoogle Scholar
• Gardner-Sood P, Lally J, Smith S, et al. Cardiovascular risk factors and metabolic syndrome in people with established psychotic illnesses: baseline data from the IMPaCT randomized controlled trial. Psychol Med. 2015;45(12):2619–2629.
   PubMed Web of Science ®Google Scholar
• Carrier P, Debette-Gratien M, Girard M, et al. Liver illness and psychiatric patients. Hepat Mon. 2016;16(12):e41564.
   PubMed Web of Science ®Google Scholar
• Lluch E, Miller BJ. Rates of hepatitis B and C in patients with schizophrenia: a meta-analysis. Gen Hosp Psychiatry. 2019;61:41–46.
   PubMed Web of Science ®Google Scholar
• Marchesini G. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome. Hepatology. 2003;37(4):917–923.
   PubMed Web of Science ®Google Scholar
• Correll CU, Detraux J, De Lepeleire J, et al. Effects of antipsychotics, antidepressants and mood stabilizers on risk for physical diseases in people with schizophrenia, depression and bipolar disorder. World Psychiatry. 2015;14(2):119–136.
   PubMed Web of Science ®Google Scholar
• Talal AH, Venuto CS, Younis I. Assessment of hepatic impairment and implications for pharmacokinetics of substance use treatment: clinical pharmacology in drug development. Clin Pharmacol Drug Dev. 2017;6(2):206–212.
   PubMed Web of Science ®Google Scholar
• Çolak Y, Afzal S, Nordestgaard BG, et al. Prognosis of asymptomatic and symptomatic, undiagnosed COPD in the general population in Denmark: a prospective cohort study. Lancet Respir Med. 2017;5(5):426–434.
   PubMed Web of Science ®Google Scholar
• Basaranoglu M, Neuschwander-Tetri BA. Nonalcoholic fatty liver disease: clinical features and pathogenesis. Gastroenterol Hepatol (N Y). 2006;2(4):282–291.
   PubMedGoogle Scholar
• Holt RIG, Mitchell AJ. Diabetes mellitus and severe mental illness: mechanisms and clinical implications. Nat Rev Endocrinol. 2015;11(2):79–89.
   PubMed Web of Science ®Google Scholar
• Vellas BJ, Albarede JL, Garry PJ. Diseases and aging: patterns of morbidity with age; relationship between aging and age-associated diseases. Am J Clin Nutr. 1992;55(6):1225S–1230S.
   PubMed Web of Science ®Google Scholar
• Nguyen TT, Eyler LT, Jeste DV. Systemic biomarkers of accelerated aging in schizophrenia: a critical review and future directions. Schizophr Bull. 2018;44(2):398–408.
   PubMed Web of Science ®Google Scholar
• Clausen T, Waal H, Thoresen M, et al. Mortality among opiate users: opioid maintenance therapy, age and causes of death. Addiction. 2009;104(8):1356–1362.
   PubMed Web of Science ®Google Scholar
• Voaklander DC, Rowe BH, Dryden DM, et al. Medical illness, medication use and suicide in seniors: a population-based case-control study. J Epidemiol Community Health. 2008;62(2):138–146.
   PubMed Web of Science ®Google Scholar
• Ward MM. Estimating disease prevalence and incidence using administrative data: some assembly required. J Rheumatol. 2013;40(8):1241–1243.
   PubMed Web of Science ®Google Scholar
• Thygesen LC, Ersbøll AK. When the entire population is the sample: strengths and limitations in register-based epidemiology. Eur J Epidemiol. 2014;29(8):551–558.
   PubMed Web of Science ®Google Scholar
• Thygesen SK, Christiansen CF, Christensen S, et al. The predictive value of ICD-10 diagnostic coding used to assess Charlson Comorbidity Index conditions in the population-based Danish National Registry of Patients. BMC Med Res Methodol. 2011;11(1):83.
   PubMed Web of Science ®Google Scholar